Nahdi Medical Company
4164
Rangering i aksjer
#4866
Nahdi Medical Company stands as a prominent pharmaceutical retail chain with... Nahdi Medical Company stands as a prominent pharmaceutical retail chain with operations spanning both the Kingdom of Saudi Arabia and the United Arab Emirates. Its extensive product portfolio encompasses a diverse range of pharmaceutical goods, health and wellness items, maternal and infant care essentials, beauty products, and various fast-moving consumer goods. Beyond retail, Nahdi provides a comprehensive suite of omni-health services, including polyclinics, rapid-care clinics, telemedicine platforms, laboratory facilities, and home healthcare programs. The company is also actively involved in the wholesale and retail distribution of cosmetics, medicines, specialized dietary products, healthy food options, and medical equipment. With approximately 1,151 pharmacies under its management, Nahdi Medical Company was established in 1986 and maintains its headquarters in Jeddah, Saudi Arabia. It operates as a subsidiary under the umbrella of both Alnahdi Holding Company Limited and Saudi Economic and Development Company Limited.
Aksjekurs
$23.30
Markedsverdi
$3.03B
Endring (1 dag)
-0.51%
Endring (1 år)
-27.10%
Land
SA
Handel Nahdi Medical Company (4164)
Kategori
Healthcare
Inntekter for Nahdi Medical Company (4164)
Inntekter i Jun 2026 TTM: $2.80B
Ifølge de nyeste økonomiske rapportene til Nahdi Medical Company er selskapets nåværende inntekter (TTM) $2.80B. I 2023 hadde selskapet inntekter på $2.32B en økning sammenlignet med inntektene i 2022, som var $2.29B. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Nahdi Medical Company fra 2017 til 2026
Inntekter ved slutten av hvert år
| År | Inntekter | Endre |
|---|---|---|
| 2026 (TTM) | $2.80B | 11.55% |
| 2024 | $2.51B | 8.21% |
| 2023 | $2.32B | 1.37% |
| 2022 | $2.29B | 6.69% |
| 2021 | $2.15B | -6.73% |
| 2020 | $2.30B | 10.44% |
| 2019 | $2.09B | 6.47% |
| 2018 | $1.96B | 4.11% |
| 2017 | $1.88B | 0.00% |
Inntekter for lignende selskaper eller konkurrenter
| Selskap | Inntekter | Forskjell i inntekter | Land |
|---|---|---|---|
| $2.54B | -9.59% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| $830.81M | -70.38% |
US
|
